Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 68.14
+0.14 (0.21%)
Jun 19, 2026, 3:43 PM AEST
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are TG Therapeutics stock at 2.00%, Travere Therapeutics at 1.93%, Alkermes at 1.89%, Twist Bioscience at 1.84%, and Revolution Medicines at 1.75%.
Total Holdings
10
Top 10 Percentage
16.79%
Asset Class
Equity
ETF Category
Health Care
Assets
43.18M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TGTX | TG Therapeutics, Inc. | 2.00% |
| 2 | TVTX | Travere Therapeutics, Inc. | 1.93% |
| 3 | ALKS | Alkermes plc | 1.89% |
| 4 | TWST | Twist Bioscience Corporation | 1.84% |
| 5 | RVMD | Revolution Medicines, Inc. | 1.75% |
| 6 | EXEL | Exelixis, Inc. | 1.50% |
| 7 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.50% |
| 8 | KRYS | Krystal Biotech, Inc. | 1.47% |
| 9 | NBIX | Neurocrine Biosciences, Inc. | 1.47% |
| 10 | NUVL | Nuvalent, Inc. | 1.44% |
As of Jun 11, 2026